糖尿病治療設備，預計到 2028 年

Diabetes Care Devices, Forecast to 2028

出版日期: 2024年05月31日 | 出版商:

Frost & Sullivan | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

AI 和 GLP-1 成長機會推動第 2 型糖尿病 (T2D) 治療設備的擴張

這項研究詳細概述了全球糖尿病治療設備產業，由於各地區糖尿病盛行率不斷上升，該產業的需求顯著增加。市場競爭激烈，既有老牌公司，也有新興Start-Ups。 OEM正在開發創新產品，以加強糖尿病護理，並將其客戶群從第 1 型糖尿病 (T1D) 患者擴展到包括第 2 型糖尿病 (T2D)、糖尿病前期，甚至非糖尿病患者。公司正在採用新穎的商務策略產生穩定的收益來源並減輕患者的經濟負擔。研究將糖尿病治療設備分為兩大類：血糖值監測和胰島素輸送。血糖值監測設備由自我血糖監測（SMBG）設備和連續血糖監測（CGM）系統組成，胰島素輸送設備由胰島素幫浦和胰島素筆組成。我們還根據糖尿病類型（T1D 和 T2D）對行業進行細分，以檢驗每種糖尿病類型的獨特市場趨勢。地理範圍包括北美、歐洲、亞太地區 (APAC)、中東和非洲、南亞 (MEASA) 和拉丁美洲。這項研究提供了與所有細分市場相關的預測、規模和趨勢分析。我們研究了競爭格局，並重點介紹了對該領域產生影響的主要企業和關鍵技術。我們確定每個細分市場的成長動力和限制因素，並分析該行業變化帶來的機會。基準年為2023年，預測期間為2024年至2028年。

This study provides a detailed overview of the global diabetes care device industry, which is witnessing a significant increase in demand due to the growing prevalence of diabetes across regions. The market, comprising both established players and emerging start-ups, is the site of fierce competition. OEMs are developing innovative, AI-equipped technology to enhance diabetes care and expand the customer base beyond patients with type 1 diabetes (T1D) to those with type 2 diabetes (T2D), prediabetes, and even those without diabetes. Companies are adopting novel business strategies that create steady revenue streams and ease patients' financial burdens. The study segments diabetes care devices into two main categories: glucose monitoring and insulin delivery. Glucose monitoring devices comprise self-monitoring of blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems, while insulin delivery devices comprise insulin pumps and insulin pens. The study also segments the industry according to diabetes type (T1D and T2D), examining the unique market dynamics of each. The geographic scope includes North America, Europe, Asia-Pacific (APAC), the Middle East, Africa, and South Asia (MEASA), and Latin America. The study provides relevant forecast, sizing, and trend analyses across all segments. It examines the competitive landscape and highlights the key players and significant technologies making an impact in this space. The study identifies the factors driving and restraining growth in each segment and analyzes the opportunities emerging from the changes in this industry for market players and stakeholders to leverage. The base year is 2023, and the forecast period is from 2024 to 2028.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Diabetes Care Device Industry
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of Analysis
Segmentation
Key Competitors
Growth Metrics
Distribution Channels
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Region
Revenue Forecast by Segment
Revenue Forecast Analysis
Pricing Trends and Forecast Analysis
Revenue Share by Segment
Competitive Environment
Revenue Share
Revenue Share Analysis

Trends in the Diabetes Care Continuum

Global Diabetes Prevalence
New Business Models
Care Setting Trends
Eco-friendly Management
Metabolic Health
New Insulin Delivery Systems
AI Integration in Diabetes Care

T1D Opportunities

T1D Patient Journey
Children and Adolescents with T1D in China
Growth Opportunity: CGM for T1D Children and Adolescents in China
China: Market Analysis and Penetration Approach
Additional Ways to Address T1D Patient Needs

T2D Opportunities

T2D Patient Journey
Global T2D Prevalence
T2D: A Global Health Concern
Reimbursement for T2D
Opportunities in T2D Presented by GLP-1
Insulin Pump Growth Opportunities in T2D

Emerging Companies

Diabeloop's DBLG1 Algorithm for Insulin Delivery
Decide Clinical Software's GlucoTab

Growth Opportunity Analysis: SMBG

SMBG Growth Metrics
SMBG Growth Drivers
SMBG Growth Restraints
SMBG Revenue Forecast
SMBG Revenue Forecast by Region
SMBG Competitors
SMBG Forecast Analysis

Growth Opportunity Analysis: CGM

CGM Growth Metrics
CGM Growth Drivers
CGM Growth Restraints
CGM Revenue Forecast
CGM Revenue Forecast by Region
CGM Key Competitors
CGM Reimbursement Trends and Market Shifts
Diversifying CGM User Base
CGM Forecast Analysis

Growth Opportunity Analysis: Insulin Pens

Insulin Pen Growth Metrics
Insulin Pen Growth Drivers
Insulin Pen Growth Restraints
Insulin Pen Revenue Forecast
Insulin Pen Revenue Forecast by Region
Insulin Pen Key Competitors
Insulin Pen Reimbursement Trends and Market Shifts
Insulin Pen Forecast Analysis

Growth Opportunity Analysis: Insulin Pumps

Insulin Pump Growth Metrics
Insulin Pump Growth Drivers
Insulin Pump Growth Restraints
Insulin Pump Revenue Forecast
Insulin Pump Revenue Forecast by Region
Insulin Pump Key Competitors
Insulin Pump Reimbursement Trends and Market Shifts
Insulin Pump Forecast Analysis

Growth Opportunity Universe

Growth Opportunity 1: Insulin Pumps for T2D patients
Growth Opportunity 2: Wearables for the Multiparametric Testing of Glucose and Lipids
Growth Opportunity 3: Eco-friendly Insulin Pens
Growth Opportunity 4: CGM for T1D Children and Adolescents in China
Growth Opportunity 5: AI-based Early Diagnosis Tools and Tests